Williams Jones Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,194
Closed -$269K 575
2022
Q3
$269K Sell
2,194
-1,768
-45% -$233K ﹤0.01% 453
2022
Q2
$527K Sell
3,962
-6
-0.2% -$818 0.01% 353
2022
Q1
$543K Sell
3,968
-1,320
-25% -$184K 0.01% 339
2021
Q4
$915K Buy
5,288
+102
+2% +$15.5K 0.01% 269
2021
Q3
$754K Sell
5,186
-1,194
-19% -$175K 0.01% 275
2021
Q2
$842K Buy
6,380
+1,262
+25% +$165K 0.01% 263
2021
Q1
$657K Sell
5,118
-1,007
-16% -$124K 0.01% 281
2020
Q4
$730K Buy
6,125
+960
+19% +$117K 0.01% 250
2020
Q3
$591K Buy
5,165
+1,465
+40% +$173K 0.01% 246
2020
Q2
$422K Buy
+3,700
New +$392K 0.01% 277

Other funds holding DGX

Williams Jones Wealth Management's DGX Position: Q4 2022 in Review

Williams Jones Wealth Management sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 2,194 shares — an estimated $269K sold.

Williams Jones Wealth Management first reported a position in DGX in Q2 2020 and held it in 10 quarters. The position peaked at $915K in Q4 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Williams Jones Wealth Management reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Williams Jones Wealth Management sold 2,194 Quest Diagnostics shares in Q4 2022, an estimated $269K.
  • Williams Jones Wealth Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 10 quarters.
  • Williams Jones Wealth Management's Quest Diagnostics position peaked at $915K in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Williams Jones Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.